Cryosite (ASX:CTE) — Material Events
ASX:CTE · 6 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Cryosite Accelerates Growth with 12% Revenue Rise and Strategic Facility ExpansionMedium
Cryosite posts 12% revenue growth, expands ultra-frozen segment, defers dividend to fund growth
21 Aug 2025
·Appendix 4E Preliminary Final Report
·85
Cryosite Doubles Storage Capacity Amid 25% Revenue SurgeMedium
Cryosite Limited reports 25% revenue growth and doubles warehouse capacity with Auburn acquisition
26 Feb 2026
·Half Year Report
·85
Cryosite Accelerates Growth with 22% Revenue Boost and New Warehouse ExpansionMedium
Cryosite posts 22% revenue growth in Q1 FY26, expands capacity with new warehouse
13 Oct 2025
·Trading Update
·80
Cryosite Posts 28% EBITDA Growth With Major Facility Expansions UnderwayMedium
Cryosite posts strong 10-month growth with infrastructure expansion and NAB refinancing
27 May 2026
·Trading Update
·80
Cryosite Secures Freehold Warehouse, Doubling Storage Capacity in SydneyMedium
Cryosite to Acquire Strategic Warehouse Facility in Sydney to Double Storage Capacity
1 Oct 2025
·Market Release
·75
No articles in this tier for the last 12 months.
Market Mentions
1
- appeared in market wrap coverage
These are market wrap articles where Cryosite (ASX:CTE) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026